Brian Van Tine, MD, Ph.D. of Washington University of School of Medicine, in St. Louis speaks about Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma.
Sarcoma type:
Synovial sarcoma, Liposarcoma, (Myxoid/Round Cell Liposarcoma specifically)
Places:
London and Manchester
Advertisement
Full Title: A phase 2 open-label single-arm clinical trial of ADP-A2M4 SPEARTM T cells in subjects with advanced synovial sarcoma or liposarcoma of myxoid/round cells
Age: 16-75 to 75
Step: Phase 2 Phase: Phase 2
This research aims to find out if the drug ADP-A2M4 is safe and how well it works to target cancer cells from synovial sarcoma or Myxoid/Round Cell Liposarcoma.